CID 124093

Garenoxacin

Structural Information

Molecular Formula
C23H20F2N2O4
SMILES
C[C@@H]1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F
InChI
InChI=1S/C23H20F2N2O4/c1-11-15-5-2-12(8-13(15)9-26-11)16-6-7-17-19(21(16)31-23(24)25)27(14-3-4-14)10-18(20(17)28)22(29)30/h2,5-8,10-11,14,23,26H,3-4,9H2,1H3,(H,29,30)/t11-/m1/s1
InChIKey
NJDRXTDGYFKORP-LLVKDONJSA-N
Compound name
1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

216
References

3413
Patents

426.1391 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 427.14638 196.5
[M+Na]+ 449.12832 206.7
[M-H]- 425.13182 201.0
[M+NH4]+ 444.17292 201.5
[M+K]+ 465.10226 198.0
[M+H-H2O]+ 409.13636 186.8
[M+HCOO]- 471.13730 207.9
[M+CH3COO]- 485.15295 204.1
[M+Na-2H]- 447.11377 193.3
[M]+ 426.13855 197.8
[M]- 426.13965 197.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe